References
- Atlas S A, Case D B, Sealey J E, Laragh J H, McKinstry D N. Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natriuresis. Hypertension 1985; 1: 274–280
- Clissold S P, Brogden R, Piretanide N. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1985; 29: 489–530
- Becker R HA, Schölkens B A, Metzger H, Schulze K J. Pharmacological properties of the new orally active angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S, 3S, 5S)-2-azabicyclo[3.3.0]octane-3-carboxylic acid (HOE 498). Arzneim-Forsch 1984; 34: 1411–1416
- DiNicolantonio R. Failure of captopril to lower blood pressure in spontaneously hypertensive rats offered water and saline to drink. Clin Exp Pharmacol Physiol 1983; 10: 269–272
- Schuster V L, Kokko J P, Jacobson H R. Angiotensin II directly stimulates transport in rabbit proximal convoluted tubules. J Clin Invest. 1984; 73: 507–515
- Puschett J B. Clinical pharmacologic implications in diuretic selection. Am J Cardiol 1986; 75: 6A–13A
- Navar L G, Rosivall L. Contribution of the renin-angiotensin system to the control of intrarenal hemody namics. Kidney Int. 1984; 25: 857–868
- Hall J E. Regulation of glomerular filtration rate and sodium excretion by angiotensin II. Federation Proc. 1986; 45: 1431–1437
- Schnermann J, Briggs J. Role of the renin-angiotensin sytem in tubuloglomerular feedback. Federation Proc. 1986; 45: 1426–1430
- Chan P S, Ronsberg M A, Cervoni P. Studies on the mechanism of the synergistic antihypertensive activity of captopril and hydrochlorothiazide following acute administration in spontaneously hypertensive rats. Clin Exp Hypertens 1982; 4(6)1019–1034